Johnson & Johnson Innovation - JJDC, Inc. (CIK 0000924020)

Latest company ownership

CVRX - CVRx, Inc.
Role: 10% Owner
Shares held
4,040,861
Last filed at
Dec 1, 2025
Confidence Score
27.5
2025Q4
Confidence Score History
2025Q4 2025Q4
Shares held
3,892,256
Last filed at
Feb 12, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4
JNJ - JOHNSON & JOHNSON
Role: 10% Owner
Shares held
1,979,173
Last filed at
Apr 10, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
Shares held
900,333
Last filed at
Aug 18, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q3 2025Q4
NGNE - Neurogene Inc.
Role: 10% Owner
Shares held
100,000
Last filed at
Aug 12, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
36,345
Last filed at
May 5, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 26, 2025 Dec 1, 2025 CVRx, Inc. 10% Owner Sell 47.5 -6,337 -0.16% ✗ $63.6K
Nov 21, 2025 Nov 25, 2025 CVRx, Inc. 10% Owner Sell 51.3 -2,700 -0.07% ✗ $27.1K
Nov 12, 2025 Nov 14, 2025 CVRx, Inc. 10% Owner Sell 51.3 -1,000 -0.02% ✗ $10K
Nov 6, 2025 Nov 10, 2025 CVRx, Inc. 10% Owner Sell 20.0 -52,532 -1.28% ✗ $536.3K
Feb 16, 2024 Mar 6, 2024 JOHNSON & JOHNSON 10% Owner Sell 47.5 -3,725 -0.09% ✗ $96.1K
Jun 30, 2020 Jul 2, 2020 JOHNSON & JOHNSON 10% Owner Buy 100.0 +725,000 24.61% ✗ $12.3M
Nov 20, 2017 Nov 22, 2017 JOHNSON & JOHNSON 10% Owner Sell 15.0 -18,367,346 -100.00% ✗ $50.5M
Aug 29, 2017 Sep 14, 2017 JOHNSON & JOHNSON 10% Owner Sell 27.5 -3,892,256 -100.00% ✗ $389.2
Aug 16, 2016 Aug 18, 2016 Protagonist Therapeutics, Inc 10% Owner Buy 100.0 +583,333 31.26% ✗ $7M
Mar 18, 2015 Feb 12, 2016 Minerva Neurosciences, Inc. 10% Owner Buy 100.0 +607,903 18.51% ✗ $3M
Aug 10, 2015 Aug 12, 2015 Neurogene Inc. 10% Owner Sell 15.0 -1,514,821 -93.81% ✗ $33.9M
Mar 13, 2015 Mar 17, 2015 Minerva Neurosciences, Inc. 10% Owner Buy 100.0 +607,903 15.62% ✗ $2.9M
Mar 12, 2014 Feb 3, 2015 Neurogene Inc. 10% Owner Buy 100.0 +272,727 19.59% ✗ $3M
Dec 16, 2014 Dec 18, 2014 Neurogene Inc. 10% Owner Sell 32.5 -8,100 -0.60% ✗ $61.7K
Dec 11, 2014 Dec 15, 2014 Neurogene Inc. 10% Owner Sell 43.8 -5,000 -0.37% ✗ $37.5K
Dec 8, 2014 Dec 10, 2014 Neurogene Inc. 10% Owner Sell 32.5 -8,300 -0.61% ✗ $64K
Dec 3, 2014 Dec 5, 2014 Neurogene Inc. 10% Owner Sell 22.5 -15,900 -1.15% ✗ $123.5K
Dec 1, 2014 Dec 3, 2014 Neurogene Inc. 10% Owner Sell 52.5 -1,200 -0.09% ✗ $9K
Nov 25, 2014 Nov 26, 2014 Neurogene Inc. 10% Owner Sell 51.3 -2,000 -0.14% ✗ $15.5K
Nov 20, 2014 Nov 24, 2014 Neurogene Inc. 10% Owner Sell 32.5 -9,500 -0.68% ✗ $77.3K
May 1, 2014 May 5, 2014 Aldeyra Therapeutics, Inc. 10% Owner Sell 20.0 -46,876 -1.33% ✗ $375K